DK3712162T3 - Smac-mimetica anvendt som iap-inhibitorer og anvendelse deraf - Google Patents
Smac-mimetica anvendt som iap-inhibitorer og anvendelse deraf Download PDFInfo
- Publication number
- DK3712162T3 DK3712162T3 DK18875727.2T DK18875727T DK3712162T3 DK 3712162 T3 DK3712162 T3 DK 3712162T3 DK 18875727 T DK18875727 T DK 18875727T DK 3712162 T3 DK3712162 T3 DK 3712162T3
- Authority
- DK
- Denmark
- Prior art keywords
- smac
- iap inhibitors
- mimetics used
- mimetics
- iap
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 229940075439 smac mimetic Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711117079 | 2017-11-13 | ||
| PCT/CN2018/115256 WO2019091492A1 (zh) | 2017-11-13 | 2018-11-13 | 用作iap抑制剂的smac模拟物及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3712162T3 true DK3712162T3 (da) | 2022-09-19 |
Family
ID=66438734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18875727.2T DK3712162T3 (da) | 2017-11-13 | 2018-11-13 | Smac-mimetica anvendt som iap-inhibitorer og anvendelse deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11358950B2 (da) |
| EP (1) | EP3712162B1 (da) |
| JP (1) | JP7257397B2 (da) |
| KR (1) | KR102707188B1 (da) |
| CN (2) | CN114685602A (da) |
| AU (1) | AU2018364218B2 (da) |
| BR (1) | BR112020009369A2 (da) |
| CA (1) | CA3082437A1 (da) |
| DK (1) | DK3712162T3 (da) |
| EA (1) | EA202091169A1 (da) |
| ES (1) | ES2927195T3 (da) |
| IL (1) | IL274598B1 (da) |
| PL (1) | PL3712162T3 (da) |
| SG (1) | SG11202004377XA (da) |
| WO (1) | WO2019091492A1 (da) |
| ZA (1) | ZA202003178B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020177765A1 (zh) * | 2019-03-07 | 2020-09-10 | 正大天晴药业集团股份有限公司 | Iap抑制剂与免疫检查点抑制剂的组合 |
| KR20220006611A (ko) * | 2019-05-10 | 2022-01-17 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | Iap 억제제로서의 smac 모방물의 결정 및 그 제조방법 |
| WO2024175554A1 (en) | 2023-02-21 | 2024-08-29 | Institut Curie | Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02125B (me) * | 2004-04-07 | 2013-04-30 | Novartis Ag | Inhibitori protein apoptoze (iap) |
| CN101035802A (zh) * | 2004-07-02 | 2007-09-12 | 健泰科生物技术公司 | Iap抑制剂 |
| ZA200704910B (en) | 2004-12-20 | 2008-09-25 | Genentech Inc | Pyrrolidine inhibitors of IAP |
| WO2008014252A2 (en) * | 2006-07-24 | 2008-01-31 | Tetralogic Pharmaceuticals Corporation | Iap inhibitors |
| EP2102229B1 (en) * | 2006-10-12 | 2014-03-26 | Novartis AG | Pyrrolydine derivatives as iap inhibitors |
| JP2010513561A (ja) * | 2006-12-19 | 2010-04-30 | ジェネンテック， インコーポレイテッド | Ｉａｐのイミダゾピリジンインヒビター |
| MX2010007948A (es) * | 2008-01-24 | 2010-10-04 | Tetralogic Pharm Corp | Inhibidores de proteinas de apoptosis. |
| NO2755614T3 (da) | 2012-01-03 | 2018-03-31 | ||
| WO2013166344A1 (en) | 2012-05-04 | 2013-11-07 | Novartis Ag | Biomarkers for iap inhibitor therapy |
-
2018
- 2018-11-13 EP EP18875727.2A patent/EP3712162B1/en active Active
- 2018-11-13 KR KR1020207015888A patent/KR102707188B1/ko active IP Right Grant
- 2018-11-13 CN CN202210145394.4A patent/CN114685602A/zh active Pending
- 2018-11-13 US US16/763,746 patent/US11358950B2/en active Active
- 2018-11-13 JP JP2020526193A patent/JP7257397B2/ja active Active
- 2018-11-13 CA CA3082437A patent/CA3082437A1/en active Pending
- 2018-11-13 IL IL274598A patent/IL274598B1/en unknown
- 2018-11-13 EA EA202091169A patent/EA202091169A1/ru unknown
- 2018-11-13 PL PL18875727.2T patent/PL3712162T3/pl unknown
- 2018-11-13 ES ES18875727T patent/ES2927195T3/es active Active
- 2018-11-13 WO PCT/CN2018/115256 patent/WO2019091492A1/zh unknown
- 2018-11-13 CN CN201880070118.8A patent/CN111247161B/zh active Active
- 2018-11-13 SG SG11202004377XA patent/SG11202004377XA/en unknown
- 2018-11-13 DK DK18875727.2T patent/DK3712162T3/da active
- 2018-11-13 AU AU2018364218A patent/AU2018364218B2/en active Active
- 2018-11-13 BR BR112020009369-6A patent/BR112020009369A2/pt unknown
-
2020
- 2020-05-28 ZA ZA2020/03178A patent/ZA202003178B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210371400A1 (en) | 2021-12-02 |
| KR20200081456A (ko) | 2020-07-07 |
| WO2019091492A1 (zh) | 2019-05-16 |
| ZA202003178B (en) | 2022-10-26 |
| CN111247161A (zh) | 2020-06-05 |
| CA3082437A1 (en) | 2019-05-16 |
| EA202091169A1 (ru) | 2020-08-06 |
| BR112020009369A2 (pt) | 2020-10-13 |
| ES2927195T3 (es) | 2022-11-03 |
| PL3712162T3 (pl) | 2022-11-14 |
| EP3712162A1 (en) | 2020-09-23 |
| CN111247161B (zh) | 2021-12-31 |
| AU2018364218A1 (en) | 2020-06-04 |
| CN114685602A (zh) | 2022-07-01 |
| EP3712162A4 (en) | 2021-08-04 |
| JP2021502397A (ja) | 2021-01-28 |
| IL274598A (en) | 2020-06-30 |
| SG11202004377XA (en) | 2020-06-29 |
| IL274598B1 (en) | 2024-09-01 |
| AU2018364218B2 (en) | 2023-03-02 |
| EP3712162B1 (en) | 2022-08-24 |
| JP7257397B2 (ja) | 2023-04-13 |
| US11358950B2 (en) | 2022-06-14 |
| KR102707188B1 (ko) | 2024-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3658557T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3328849T3 (da) | 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer | |
| DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
| DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
| DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3347472T3 (da) | Sammensætninger som indeholder cyp76ad1- clade polypeptider og anvendelse heraf. | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| DK3307707T3 (da) | Halogensubstituerede phenoxyphenylamidiner og anvendelsen deraf som fungicider | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3672976T3 (da) | Bcl-2-hæmmere | |
| DK3606519T3 (da) | ASK1-inhibitorforbindelser og anvendelser deraf | |
| DK3538528T3 (da) | Pyrrolamider som alpha v-integrinhæmmere | |
| DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
| DK3078365T3 (da) | Solubiliseringsmidler og vandige sammensætninger omfattende disse | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| DK3426243T3 (da) | 3-phosphoglyceratdehydrogenase-inhibitorer og anvendelser deraf | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| DK3280405T3 (da) | Inhibitorer og anvendelser deraf | |
| DK3365321T3 (da) | Solabegron-zwitterion og anvendelser deraf |